Global Bio-chem Technology Group Company Limited
GBCMY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 7.6% | 22.7% | 26.3% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 13.6% | 13.8% | 7.3% | 11.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 2.2% | -4.6% | -9.9% | -12.5% |
| Other Income/Exp. Net | -$0 | $1 | -$0 | $4 |
| Pre-Tax Income | -$0 | $1 | -$0 | $4 |
| Tax Expense | $0 | -$0 | $0 | -$0 |
| Net Income | -$0 | $1 | -$0 | $4 |
| % Margin | -13% | 84.1% | -17.6% | 602.9% |
| EPS | -0.87 | 5 | -0.88 | 24 |
| % Growth | -117.4% | 668.2% | -103.7% | – |
| EPS Diluted | -0.87 | 5 | -0.88 | 24 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | -$0 | $0 | -$0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $4 |
| % Margin | 4.8% | 4.3% | 11.3% | 604.1% |